Some Clouds For PhRMA In Sunshine Act: Revised Bill Loosens Pre-emption
Executive Summary
Sens. Herb Kohl, D-Wis., and Chuck Grassley, R-Iowa, have narrowed state pre-emption provisions in their latest Physician Payments Sunshine Act
You may also be interested in...
Sunshine Bill Trade-Off: Stronger Pre-emption Would Mean More Disclosure
Increased pre-emption under the Physician Payment Sunshine Act is possible if the federal law is expanded to include all or most provisions under state disclosure laws, Senate Finance Committee Investigative Counsel Christopher Armstrong said at the National Disclosure Summit in Washington, D.C
Sunshine Bill Trade-Off: Stronger Pre-emption Would Mean More Disclosure
Increased pre-emption under the Physician Payment Sunshine Act is possible if the federal law is expanded to include all or most provisions under state disclosure laws, Senate Finance Committee Investigative Counsel Christopher Armstrong said at the National Disclosure Summit in Washington, D.C
Sunshine Act May Require Industry To “Forgo” Independence From CME, Sen. Grassley Says
Reporting requirements under the proposed Physician Payment Sunshine Act could mean removing the firewall between pharma and CME providers.